Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ishima T"" wg kryterium: Autor


Tytuł:
A Simple, Fast, Sensitive LC-MS/MS Method to Quantify NAD(H) in Biological Samples: Plasma NAD(H) Measurement to Monitor Brain Pathophysiology.
Autorzy:
Ishima T; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Japan.
Kimura N; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Japan.
Kobayashi M; Department of Pediatrics, Jichi Medical University, Shimotsuke 329-0498, Japan.
Nagai R; Jichi Medical University, Shimotsuke 329-0498, Japan.
Osaka H; Department of Pediatrics, Jichi Medical University, Shimotsuke 329-0498, Japan.
Aizawa K; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Japan.; Clinical Pharmacology Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Japan.; Division of Translational Research, Clinical Research Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 15; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
NAD*/metabolism
Brain Diseases*
Mice ; Animals ; Chromatography, Liquid ; Liquid Chromatography-Mass Spectrometry ; Tandem Mass Spectrometry ; Brain/metabolism ; Oxidation-Reduction
Czasopismo naukowe
Tytuł:
Multi-Omics of Familial Thoracic Aortic Aneurysm and Dissection: Calcium Transport Impairment Predisposes Aortas to Dissection.
Autorzy:
Tomida S; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
Ishima T; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
Sawaki D; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
Imai Y; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
Nagai R; Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
Aizawa K; Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.; Clinical Pharmacology Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Tochigi, Japan.; Division of Translational Research, Clinical Research Center, Jichi Medical University Hospital, Shimotsuke 329-0498, Tochigi, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 16; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article
MeSH Terms:
Calcium*/metabolism
Aortic Aneurysm, Thoracic*/metabolism
Mice ; Animals ; Multiomics ; Aorta/metabolism ; Aorta, Thoracic/pathology
SCR Disease Name:
Aortic Aneurysm, Familial Thoracic 1
Czasopismo naukowe
Tytuł:
Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622.
Autorzy:
Yang Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Ishima T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Wan X; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Wei Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Chang L; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Zhang J; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Qu Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan. .
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2022 Apr; Vol. 272 (3), pp. 483-495. Date of Electronic Publication: 2021 Sep 04.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*/drug effects
Macrophage Colony-Stimulating Factor*/antagonists & inhibitors
Organic Chemicals*/pharmacology
Animals ; Fatty Acids, Volatile/metabolism ; Humans ; Mice ; Mice, Inbred C57BL ; Microglia/metabolism
Czasopismo naukowe
Tytuł:
Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine.
Autorzy:
Zhang K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.; Department of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, 238000, China.
Sakamoto A; Department of Biomedical Science, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
Chang L; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Qu Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Wang S; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Pu Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Tan Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Wang X; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Fujita Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Ishima T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Hatano M; Department of Biomedical Science, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan. .
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2021 Apr; Vol. 271 (3), pp. 447-456. Date of Electronic Publication: 2019 Dec 24.
Typ publikacji:
Journal Article
MeSH Terms:
Resilience, Psychological*
Social Defeat*
Antidepressive Agents/*pharmacology
Depressive Disorder, Major/*immunology
Disease Susceptibility/*immunology
Ketamine/*pharmacology
NK Cell Lectin-Like Receptor Subfamily K/*drug effects
Spleen/*drug effects
Spleen/*immunology
Stress, Psychological/*drug therapy
Stress, Psychological/*immunology
Animals ; Antidepressive Agents/administration & dosage ; Autopsy ; Behavior, Animal/drug effects ; Disease Models, Animal ; Humans ; Ketamine/administration & dosage ; Mice ; Mice, Inbred C57BL ; Parietal Lobe/immunology ; Spleen/pathology
Czasopismo naukowe
Tytuł:
Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation.
Autorzy:
Fujita Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Fujita A; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Ishima T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Hirai A; Innovation Division, Kagome Co., Ltd., Nasushiobara, Japan.
Suzuki S; Innovation Division, Kagome Co., Ltd., Nasushiobara, Japan.
Suganuma H; Innovation Division, Kagome Co., Ltd., Nasushiobara, Japan.
Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2020 Sep; Vol. 40 (3), pp. 268-274. Date of Electronic Publication: 2020 May 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glucosinolates/*administration & dosage
Neurodevelopmental Disorders/*immunology
Neurodevelopmental Disorders/*prevention & control
Oximes/*administration & dosage
Prenatal Exposure Delayed Effects/*immunology
Prenatal Exposure Delayed Effects/*prevention & control
Sulfoxides/*administration & dosage
Animals ; Cognition/drug effects ; Cognition/physiology ; Female ; Lactation/drug effects ; Lactation/immunology ; Male ; Mice ; Neurodevelopmental Disorders/psychology ; Pregnancy ; Prenatal Exposure Delayed Effects/psychology
Czasopismo naukowe
Tytuł:
Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve.
Autorzy:
Wang S; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Ishima T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Zhang J; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Qu Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Chang L; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Pu Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Fujita Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Tan Y; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Wang X; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2020 Aug 15; Vol. 17 (1), pp. 241. Date of Electronic Publication: 2020 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
Lactobacillus*
Limosilactobacillus reuteri*
Anhedonia/*drug effects
Anti-Bacterial Agents/*pharmacology
Depression/*microbiology
Vagus Nerve/*microbiology
Animals ; Depression/blood ; Gastrointestinal Microbiome ; Interleukin-6/blood ; Mice ; Motor Activity/drug effects ; Stress, Psychological/blood ; Stress, Psychological/microbiology
SCR Organism:
Lactobacillus intestinalis
Czasopismo naukowe
Tytuł:
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.
Autorzy:
Kudo N; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
Yamamori H; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.; Japan Community Health care Organization Osaka Hospital, Osaka, Japan.
Ishima T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Nemoto K; Department of Neuropsychiatry Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
Yasuda Y; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.; United Graduate School of Child Development, Osaka University, Suita, Japan.; Life Grow Brilliant Mental Clinic, Osaka, Japan.
Fujimoto M; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
Azechi H; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
Niitsu T; Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, Japan.
Numata S; Department of Psychiatry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Ikeda M; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
Iyo M; Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohmori T; Department of Psychiatry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Fukunaga M; Division of Cerebral Integration, National Institute for Physiological Sciences, Okazaki, Japan.
Watanabe Y; Department of Radiology, Shiga University of Medical Science, Otsu, Japan.
Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Hashimoto R; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.; United Graduate School of Child Development, Osaka University, Suita, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2020 Jun; Vol. 40 (2), pp. 150-156. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Schizophrenic Psychology*
Cognition/*physiology
Matrix Metalloproteinase 9/*blood
Schizophrenia/*blood
Schizophrenia/*diagnosis
Adult ; Antipsychotic Agents/pharmacology ; Antipsychotic Agents/therapeutic use ; Biomarkers/blood ; Cognition/drug effects ; Cohort Studies ; Female ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Schizophrenia/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies